MDT
95.61
+0.82%↑
VEEV
300.34
+2.34%↑
A
138.64
-0.03%↓
HQY
89.66
-1.24%↓
PHR.US
22.83
+1.69%↑
MDT
95.61
+0.82%↑
VEEV
300.34
+2.34%↑
A
138.64
-0.03%↓
HQY
89.66
-1.24%↓
PHR.US
22.83
+1.69%↑
MDT
95.61
+0.82%↑
VEEV
300.34
+2.34%↑
A
138.64
-0.03%↓
HQY
89.66
-1.24%↓
PHR.US
22.83
+1.69%↑
MDT
95.61
+0.82%↑
VEEV
300.34
+2.34%↑
A
138.64
-0.03%↓
HQY
89.66
-1.24%↓
PHR.US
22.83
+1.69%↑
MDT
95.61
+0.82%↑
VEEV
300.34
+2.34%↑
A
138.64
-0.03%↓
HQY
89.66
-1.24%↓
PHR.US
22.83
+1.69%↑
24h
Current
Min
2.56
Max
2.94
Recommendations | Buy |
---|---|
12 Months Forecast | +466.41% upside |
Next Earnings | 12 Nov 2025 |
---|
Past performance is not a reliable indicator of future results.
1 Oct 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Read
10 Mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Read
10 Mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Read
10 Mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Read
10 Mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Read
10 Mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Read
10 Mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
10 Mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 14.5 USD 466.41%
High 17 USD
Low 12 USD
Based on 2 Wall Street analysts offering 12 month price targets forFortress Biotech Inc - Dist in the last 3 months.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Based on 2 analysts giving stock ratings to Fortress Biotech Inc - Dist in the past 3 months.
$